Markets:

Overview

News

Currencies

International

Treasuries

Alector, Inc. - Common Stock (NQ:ALEC)

1.945 +0.015 (+0.78%)

Streaming Delayed Price Updated: 2:36 PM EST, Jan 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Alector, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Alector Appoints Neil Berkley as Chief Financial Officer and Chief Business Officer

December 12, 2025

From Alector, Inc.

Via GlobeNewswire

Alector to Participate in the Bank of America CNS Therapeutics Conference

December 01, 2025

From Alector, Inc.

Via GlobeNewswire

ALEC Investors Have Opportunity to Join Alector, Inc. Fraud Investigation with the Schall Law Firm

November 26, 2025

From Schall Law

Via GlobeNewswire

ALEC Investors Have Opportunity to Join Alector, Inc. Fraud Investigation with the Schall Law Firm

November 19, 2025

From Schall Law

Via GlobeNewswire

ALEC Investors Have Opportunity to Join Alector, Inc. Fraud Investigation with the Schall Law Firm

November 11, 2025

From The Schall Law Firm

Via Business Wire

Alector Reports Third Quarter 2025 Financial Results and Provides Business Update

November 06, 2025

From Alector, Inc.

Via GlobeNewswire

Which stocks have an unusual volume on Friday? ↗

October 24, 2025

Volume analysis on 2025-10-24: stocks with an unusual volume in today's session.

Via Chartmill

Let's take a look at the stocks that are in motion in today's session. ↗

October 22, 2025

Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

Crude Oil Gains Over 1%; AT&T Shares Slide After Q3 Results ↗

October 22, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 22, 2025

Via Benzinga

Top movers in Wednesday's session ↗

October 22, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

Clinical Failure Halts Alector's Dementia Program, Company Reduces Workforce ↗

October 22, 2025

Alector's Phase 3 trial for FTD-GRN drug, latozinemab, failed the clinical co-primary endpoint. The program is discontinued; Alector cuts 49% of staff.

Via Benzinga

There are notable gap-ups and gap-downs in today's session. ↗

October 22, 2025

Let's have a look at the gap up and gap down stocks in today's session.

Via Chartmill

Dow Falls 100 Points; Netflix Shares Tumble On Downbeat Earnings ↗

October 22, 2025

Via Benzinga

Topics Stocks

Wednesday's pre-market session: top gainers and losers ↗

October 22, 2025

The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Via Chartmill

Netflix Posts Downbeat Earnings, Joins Aveanna Healthcare, Texas Instruments And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

October 22, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 22, 2025

Via Benzinga

Why Intuitive Surgical Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket ↗

October 22, 2025

Via Benzinga

AT&T, Netflix And 3 Stocks To Watch Heading Into Wednesday ↗

October 22, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 21, 2025

Via Benzinga

Which stocks are moving after the closing bell on Tuesday? ↗

October 21, 2025

Discover the top movers in Tuesday's after-hours session and stay informed about the post-market dynamics.

Via Chartmill

Alector Announces Topline Results from Latozinemab Phase 3 Trial in Individuals with Frontotemporal Dementia Due to a GRN Mutation and Provides Business Update

October 21, 2025

From Alector, Inc.

Via GlobeNewswire

4 Biotechnology Stocks Lead Momentum Gains Amid Strong Technicals ↗

October 10, 2025

4 biotech stocks—ALDX, ALEC, BDTX, CHRS—show strong week-on-week momentum ranking gains and improving technical indicators.

Via Benzinga

Alector to Host Virtual Research and Development Event Highlighting PGRN Franchise and Brain Carrier Programs

September 16, 2025

--Agenda to feature latozinemab and AL101, along with progress in Alector Brain Carrier–enabled programs, including new lead candidates--

From Alector, Inc.

Via GlobeNewswire

Top 4 Biotech Stocks Set For A Breakout: Momentum Scores Surge ↗

September 08, 2025

Several biotech stocks are showing renewed strength over the past week, with their Momentum scores soaring in Benzinga's Edge Stock Rankings.

Via Benzinga

Alector to Participate in Upcoming Healthcare Conferences

August 28, 2025

From Alector, Inc.

Via GlobeNewswire

Top stock movements in today's session. ↗

August 08, 2025

Curious to know what's happening on the US markets one hour before the close of the markets on Friday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 08, 2025

Via Benzinga

These stocks are moving in today's session ↗

August 08, 2025

Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

Alector (ALEC) Q2 Revenue Falls 48% ↗

August 07, 2025

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.